ANGPTL2 and atherosclerosis: In this mouse model of atherosclerosis, angptl2 down-regulation not only decreased markers of senescence and lowered monocyte recruitment and inflammation in the endothelium, but it also stimulated endothelial repair and slowed atherogenesis [97], demonstrating that angptl2+/p21+ vascular senescent cells contribute to the atherogenic process.